Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Lexicon Genetics reaches agreement with several institutions for custom knockout mice

June 23, 1999

Aurora Biosciences and Pfizer sign technology acquisition agreement

June 23, 1999

PRL-2915: a potent, subtype-selective SRIF antagonist from Biomeasure, Tulane

June 22, 1999

Evotec BioSystems and Pfizer enter drug discovery alliance

June 18, 1999

ChemRx and DuPont sign chemistry collaboration

June 15, 1999

Selective Genetics and Biomet form alliance for orthopedic therapy

June 11, 1999

Two U.S. patents licensed to Aastrom broaden coverage for cell therapy technologies

June 8, 1999

Roche and Sangamo sign Universal GeneTools research agreement

June 8, 1999

GenVec obtains rights to patents covering HSV vectors for gene therapy in nervous system disorders

June 7, 1999

Dimethaid commences new topical antifungal study

June 4, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 24, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...